Abu Dhabi, UAE – June03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, andArcera Life Sciences (“Arcera”), a global life sciences company focused on advancing innovative and sustainable healthcare solutions, havesigned a Memorandum of Understanding (MoU) to formalize a strategic, non-exclusive collaboration focused on advancing biopharma localization, clinical developmentand next-generation … Continue reading M42 and ArceraPartner to Advance Biopharma Localization and Next Generation Life Sciences in Abu Dhabi
